Factors affecting responsiveness of vadadustat in patients with anemia associated with chronic kidney disease: a post-hoc subgroup analysis of Japanese phase 3 randomized studies.

In the post-hoc study of roxadustat in patients with NDD-CKD and HDD-CKD, while the maintenance dose of roxadustat was not affected by baseline high-sensitive (hs)-CRP, the maintenance dose of darbepoetin alfa did show an increasing trend in the high hs-CRP group [ 11 , 12 ].

also in 63,971 other papers